Alpha Teknova (TKNO) Change in Accured Expenses (2020 - 2026)
Alpha Teknova (TKNO) posted quarterly Change in Accured Expenses of -$772000.0 for Q1 2026, up 24.09% year-over-year from -$622126.8 in Q1 2025, and down 263.56% quarter-over-quarter from $472000.0 in Q4 2025.
Alpha Teknova (TKNO) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has reported Change in Accured Expenses for 7 consecutive years, with -$772000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 24.09% year-over-year to -$772000.0; the TTM figure through Mar 2026 stood at $318000.0 (changed 0.0% YoY), while the FY2025 annual figure was $73000.0, up 118.77% from the prior year.
- Change in Accured Expenses slipped to -$772000.0 in Q1 2026 per TKNO's latest filing, from $472000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $2.0 million in Q3 2023 and bottomed at -$1.7 million in Q1 2024.
- Historically, Change in Accured Expenses has averaged $60941.2 across 5 years, with a median of -$135000.0 in 2025.
- On a YoY basis, Change in Accured Expenses climbed as much as 824.03% in 2023 and fell as far as 314.71% in 2023.
- Alpha Teknova's Change in Accured Expenses stood at -$155000.0 in 2022, then surged by 823.23% to $1.1 million in 2023, then plunged by 70.12% to $335000.0 in 2024, then soared by 40.9% to $472000.0 in 2025, then tumbled by 263.56% to -$772000.0 in 2026.
- Business Quant data shows TKNO's Change in Accured Expenses at -$772000.0 in Q1 2026, $472000.0 in Q4 2025, and $753000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alpha Teknova | 374.37 Mn | 356.94 Mn | 4.89 Mn | 113,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 113,000.00 |
| Jun 30, 2026 | 113,000.00 |
| Mar 31, 2026 | -772,000.00 |
| Mar 31, 2026 | -772,000.00 |
| Dec 31, 2025 | 472,000.00 |
| Dec 31, 2025 | 472,000.00 |
| Sep 30, 2025 | 753,000.00 |
| Sep 30, 2025 | 753,000.00 |
| Jun 30, 2025 | -135,000.00 |
| Jun 30, 2025 | -135,000.00 |
| Mar 31, 2025 | -1.02 Mn |
| Mar 31, 2025 | -1.02 Mn |
| Dec 31, 2024 | 335,000.00 |
| Dec 31, 2024 | 335,000.00 |
| Sep 30, 2024 | 1.04 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | -40,000.00 |
| Jun 30, 2024 | -40,000.00 |
| Mar 31, 2024 | -1.72 Mn |
| Mar 31, 2024 | -1.72 Mn |